JPS6012032B2 - bilirubin oxidase NS-1 - Google Patents

bilirubin oxidase NS-1

Info

Publication number
JPS6012032B2
JPS6012032B2 JP57025613A JP2561382A JPS6012032B2 JP S6012032 B2 JPS6012032 B2 JP S6012032B2 JP 57025613 A JP57025613 A JP 57025613A JP 2561382 A JP2561382 A JP 2561382A JP S6012032 B2 JPS6012032 B2 JP S6012032B2
Authority
JP
Japan
Prior art keywords
bilirubin
enzyme
oxidase
bilirubin oxidase
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57025613A
Other languages
Japanese (ja)
Other versions
JPS58141783A (en
Inventor
憲彰 田中
澤夫 村尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amano Enzyme Inc
Original Assignee
Amano Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amano Pharmaceutical Co Ltd filed Critical Amano Pharmaceutical Co Ltd
Priority to JP57025613A priority Critical patent/JPS6012032B2/en
Priority to DE3249743A priority patent/DE3249743C2/de
Priority to DE19823239236 priority patent/DE3239236A1/en
Priority to FR8217632A priority patent/FR2521589B1/en
Priority to GB08230397A priority patent/GB2115926B/en
Priority to US06/436,385 priority patent/US4554249A/en
Priority to CA000414104A priority patent/CA1185883A/en
Publication of JPS58141783A publication Critical patent/JPS58141783A/en
Priority to CA000464110A priority patent/CA1218586A/en
Priority to FR8419005A priority patent/FR2556010B1/en
Priority to GB08431875A priority patent/GB2152215B/en
Publication of JPS6012032B2 publication Critical patent/JPS6012032B2/en
Priority to US06/749,425 priority patent/US4839279A/en
Expired legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Description

【発明の詳細な説明】 本発明は微生物の生産する新規ビリルビンオキシダーゼ
NS−1(Bilimbin0ki船seNS−1)に
関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel bilirubin oxidase NS-1 (Bilimbin0ki seNS-1) produced by a microorganism.

本発明者等はすでに本酵素の製造法について特許出願(
特腰昭56−45503)済みであるが、その後の研究
により本酵素が新規物質であるとの結論に至った。従来
ビリルビンに反応する酵素としては、ラット、ギーニア
ピッグ等の動物脳中に存在することが知られていたが、
その酵素的性質は明らかにされていない。
The inventors have already applied for a patent on the method for producing this enzyme (
However, subsequent research led to the conclusion that this enzyme is a new substance. Previously, enzymes that react with bilirubin were known to exist in the brains of animals such as rats and guinea pigs.
Its enzymatic properties have not been clarified.

又、最近、動物以外にもきのこの一種であるアガリカス
(Agaricus)属菌にビリルビンを酸化し、過酸
化水素を生成する作用を有する物質の報告(特関昭54
一151193号公報)がある。しかし、このものの酵
素的性質は全く明示されていない。従って、ビリルビン
反応酵素の存在は知られているとは云うものの、酵素の
性質等については未知のものであり、国際酵素分類にも
未だ登録されていない状態である。しかしながら、ビリ
ルビンオキシダーゼは血液、尿など体液中のピリルビン
を定量し、肝疾患の診断に、あるいは屍尿処理水の脱色
などへの利用が大いに期待されるものである。
In addition, recently, there has been a report on a substance that has the effect of oxidizing bilirubin and producing hydrogen peroxide in bacteria of the genus Agaricus, which is a type of mushroom, in addition to animals.
No. 1151193). However, the enzymatic properties of this substance have not been clarified at all. Therefore, although the existence of bilirubin-reacting enzyme is known, the properties of the enzyme are unknown, and it has not yet been registered in the International Classification of Enzymes. However, bilirubin oxidase is highly expected to be used for quantifying pirirubin in body fluids such as blood and urine, for diagnosing liver diseases, and for decolorizing cadaver urine treated water.

本発明者等は広く自然界よりビリルビンに反応する酵素
生産菌を求め鋭意検討した結果、ミロセシゥム属に属す
る一菌株がビリルビンを酸化する酵素生産能を有するこ
とを見出し、この酵素を精製し、諸性質を調べることに
成功し、はじめてビリルビンオキシダーゼNS−1を明
らかにすることができた。
The present inventors searched widely for enzyme-producing bacteria that react with bilirubin from nature, and as a result of intensive studies, they discovered that a strain belonging to the genus Myrocesium has the ability to produce an enzyme that oxidizes bilirubin. We succeeded in investigating this and were able to clarify bilirubin oxidase NS-1 for the first time.

更に検索を続けたところミロセシウム属の保存菌株にお
いても同じ酵素を生産することがわかつた。本発明はこ
れらの知見により完成されたものであり、本発明者等が
スクリーニングして得たビリルピンオキシダーゼNS−
1生産菌はミロセシウム・ベルカリアMT−1(Myr
othec肌mvermcaria MT− 1)FE
RM − PNo.5918(PERMBP−653と
変更)として工業技術院微生物工業技術研究所に寄託さ
れている。
Further searching revealed that preserved strains of the genus Myrocesium also produced the same enzyme. The present invention was completed based on these findings, and the bilirupine oxidase NS-
1-producing bacterium is Myrocesium bercaria MT-1 (Myr
othec skin mvermcaria MT-1) FE
RM-PNo. 5918 (changed to PERMBP-653) and has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology.

本発明におけるビリルビンオキシダーゼNS−1生産菌
の例示としては更に次の菌株があげられる。
Further examples of the bilirubin oxidase NS-1 producing bacteria in the present invention include the following strains.

Myr。Myr.

theC肌m VermCariaIF。6113My
r。
theC skin m VermCariaIF. 6113My
r.

theCi山m VermCariaIF。6133M
yr。
theCiyamaVermCariaIF. 6133M
yr.

theCi山m VermCaria1F。6351M
yr。
theCi Yamam VermCaria1F. 6351M
yr.

theCi山m VermCaria IF。9056
Myr。
the Ciyama VermCaria IF. 9056
Myr.

theCi肌m CinCt山m IF。9
950Myrothecimm roridum
IFO9531次にMyrothecimmver
mcariaMT−1の菌学的性質を示す。
theCi skin m CinCt mountain m IF. 9
950 Myrothecimm roridum
IFO9531 then Myrothecimmver
The mycological properties of mcariaMT-1 are shown.

■ 形態学的性質 菌糸は無色〜白色、滑面、隔壁あり、幅1.5〜3.0
仏である。
■ Morphological properties Hyphae are colorless to white, smooth, with septa, width 1.5-3.0
It is Buddha.

分生子形成構造は、暗いオリーブ色〜黒緑色の分生子座
上に集る。分生子柄は、子座層から形成され、繰り返し
分岐し、それぞれの分岐部で2〜4本の分枝を生じ、最
後の分枝上にフィアラィドを着生、無色〜白色、隔壁あ
り。フィァラィドは3〜6本が輪生、互いに密着し平行
した層となる。円柱形、11.5一18.0一×1.5
〜2.0仏である。分生子はフィアロ型分生子、紡錘形
、7.0一8.0〃×2.0−3.0ム、一端はとがり
、他端は裁断状、とがった先端上に扇形の付属物が認め
られる。子座上に暗いオリーブ色〜黒緑色の粘塊となっ
て集まる。【Bー 生育状態 ■ 麦芽エキス寒天培地 生育はやや抑制的である。
Conidiogenic structures are clustered on dark olive to black-green conidia. The conidiophore is formed from the ascoccal layer and branches repeatedly, producing 2 to 4 branches at each branch, with phialides epiphytic on the last branch, colorless to white, with septa. Phialids grow in whorls of 3 to 6, closely attached to each other in parallel layers. Cylindrical shape, 11.5 x 18.0 x 1.5
~2.0 Buddha. Conidia are phialoid conidia, spindle-shaped, 7.0-8.0 x 2.0-3.0 mm, one end is pointed, the other end is truncated, and a fan-shaped appendage is observed on the pointed tip. . It gathers as a dark olive to black-green sticky mass on the constellation. [B-Growth status■ Growth on malt extract agar medium is somewhat suppressed.

菌糸は無色〜白色、羊毛状である。The hyphae are colorless to white and woolly.

分生子形成構造は暗いオリーブ色〜黒緑色の分生子座に
集まる。無色の分泌物が形成される。集落裏面はうす黄
〜うす蓋茶色である。■ バレィショ・ブドウ糖寒天塔
地 生育は速やかである。
Conidiogenic structures are clustered in dark olive to black-green conidia. A colorless secretion is formed. The back side of the colony is light yellow to light brown. ■ Potato/glucose agar growth is rapid.

菌糸は無色〜白色、羊毛状である。The hyphae are colorless to white and woolly.

分生子形成構造は、暗いオリ−ブ色〜黒緑色の分生子座
に集まる。無色の分泌物が形成される。集落裏面は、う
す黄茶〜にふく黄である。(C} 生理的性質 ■ 最適生育条件 温度は30qo付近がよく、軸は5〜7がよい。
Conidiogenic structures are clustered in dark olive to black-green conidia. A colorless secretion is formed. The back side of the village is pale yellow-brown to dark yellow. (C} Physiological properties■ Optimum growth condition temperature is preferably around 30 qo, and axis is preferably 5 to 7.

■ 生育の範囲 8℃で生育する。■ Growth range Grows at 8°C.

370で生育するが4500では生育しない。It grows at 370 but not at 4500.

柵は3.5〜9.5で生育する。以上の諸性質から、本
菌株は、有性生殖器官が認められないので、不完全菌類
に分離される。さらに分生子殻(pycnidi山m)
、分生子堆(acewのus)が形成されないので不完
全菌類の中でも線菌類(Hyphomycetes)に
属することが判明した。バロ ン〔Barron,G.
L.,The Genera 。
Fences grow between 3.5 and 9.5. Based on the above properties, this strain is classified as Deuteromycetes, as no sexual reproductive organs are observed. In addition, conidia (pycnidia m.)
, it was found that it belongs to the Hyphomycetes among the Deuteromycetes because no conidiophores (acew us) are formed. Barron, G.
L. , The Genera.

fHyphomycetes from soil,
Wmiams &Wilkins,母ltimore
(19斑)〕に従って検索すると、■フィアロ型分生子
を形成する。■分生子座を形成する。■分生子は紡錘形
で隔壁がない。■分生子は暗いオリーブ色〜黒緑色の粘
塊となる等によりミロセシウム属(Myrotheci
肌m属)に分類される。種については、ツロツク〔T山
IMh,M.,Thegen瓜 MyrotheCju
m Tode eX Fr,MyCol,Pap,CM
川o.130,1−42(1972)〕に従って検索す
ると、■剛毛を形成しない。
fHyphomycetes from soil,
Wmiams & Wilkins, mother ltimore
(19 spots)], ■ Phialo-type conidia are formed. ■ Forms conidia. ■Conidia are spindle-shaped and have no septa. ■The conidia become dark olive-colored to black-green sticky lumps, and are of the genus Myrotheci.
It is classified as genus m). For seeds, see Turotsuku [Tyama IMh, M. ,Thegen Melon MyrotheCju
m Tode eX Fr,MyCol,Pap,CM
River o. 130, 1-42 (1972)], ① does not form setae.

■分生子の長さは10仏以下である。■分生子表面は、
縞状ではない。■フィアラィドは円柱形である。■先端
が球状の周縁菌糸を形成しない。■分生子は紡錘形で一
端に扇状の付属物をつける。以上の諸性質によって、本
菌株はミロセシウム・ベルカリア(Myrotheci
mmvermcaria)に属するものと同定された。
■The length of conidia is less than 10 Buddhas. ■The conidial surface is
Not striped. ■Fialid is cylindrical. ■Does not form peripheral hyphae with spherical tips. ■Conidia are spindle-shaped with a fan-shaped appendage attached to one end. Due to the above properties, this strain is Myrotheci
mmvermcaria).

本発明において、ビリルビンオキシダーゼNS−1生産
菌株を培養する好適な培地としては、炭素源、窒素源、
無機物、その他栄養素を程よく含有する培地ならば、合
成培地、天然塔地のいずれにても使用可能である。
In the present invention, a suitable medium for culturing the bilirubin oxidase NS-1 producing strain includes a carbon source, a nitrogen source,
Both synthetic and natural media can be used as long as the medium contains appropriate amounts of minerals and other nutrients.

なお本発明のビリルビンオキシダーゼNS−1は、銅酵
素であるため、硫酸銅の添加がより好ましく、例えば5
脚の添加により約70%も酵素生産の増大が認められる
。培地は液状でも固状でもよいが、通常液体培地を使用
するのが工業的に有利である。そして液体堵地による培
養については、静暦培養法、濃伴培養法、通気培養法な
ど適宜選択し得るが、大量に培養するには、深部通気培
養によるのが有利である。培養温度は、20〜35午0
にて48〜11餌時間培養する。
In addition, since the bilirubin oxidase NS-1 of the present invention is a copper enzyme, it is more preferable to add copper sulfate, for example, 5
Addition of legs increases enzyme production by about 70%. Although the medium may be liquid or solid, it is usually industrially advantageous to use a liquid medium. For culture using liquid soil, a static culture method, a concentrated culture method, an aeration culture method, etc. can be selected as appropriate, but deep aeration culture is advantageous for culturing in large quantities. Cultivation temperature is 20-35 p.m.
Culture for 48 to 11 feeding hours.

こうして培養液中にピリルピンオキシダーゼNS−1が
箸量生産する。
In this way, a large amount of pirirupine oxidase NS-1 is produced in the culture solution.

そして生産蓄積されたビリルピンオキシダーゼNS−1
は、次のごとき方法で精製される。まず培養液を菌体分
離し、0.8飽和まで硫安を加え、一晩5℃に放置後、
沈澱部分を溶解し、イオン交換水を用い、5℃で十分透
析する。
And the accumulated production of bilirupine oxidase NS-1
is purified by the following method. First, isolate the cells from the culture solution, add ammonium sulfate to 0.8 saturation, and leave it at 5°C overnight.
The precipitated portion is dissolved and thoroughly dialyzed using ion-exchanged water at 5°C.

透折終了後、透折内液に活性炭を0.7%量添加し、櫨
過する。譲渡液のpHを7.4に調整し、さらに活性炭
を0.2%量を添加し、櫨過する。
After the diafiltration is completed, activated carbon is added in an amount of 0.7% to the diafiltration solution, and the mixture is filtered through a filter. The pH of the transfer liquid was adjusted to 7.4, and 0.2% of activated carbon was added and filtered.

この櫨液を0.鮒アンモニア水でpH9.3に調整後、
あらかじめ0.019のNa2C03−NaHC03緩
衝液(pH9.3)で平衡化したQAE−Sephad
ex A−50のカラムクロマトグラフイーにかけ、ビ
リルビンオキシダーゼNS−1を吸着せしめ、洗浄後、
同緩衝液(0.015〜0.3M)でグラジェントに溶
出し、活性画分を分子量1000のアミコン膜で脱塩濃
縮し、さらに0.03MNa2C03−NaHC03緩
衝液で平衡化したセフアデックスG−100のカラムに
チャージし、溶出してくるビリルピンオキシダーゼNS
−1活性画分を集め凍結乾燥を行うことにより精製ビリ
ルビンオキシダーゼNS−1を得た。この精製品はポリ
ァクリルァミドゲルディスク電気泳動的に単一であった
。次に本発明におけるビリルビンオキシダーゼ活性の測
定について述べる。
Add this citrus liquid to 0. After adjusting the pH to 9.3 with carp ammonia water,
QAE-Sephad pre-equilibrated with 0.019 Na2C03-NaHC03 buffer (pH 9.3)
Ex A-50 column chromatography was applied to adsorb bilirubin oxidase NS-1, and after washing,
Gradient elution was performed with the same buffer (0.015-0.3M), and the active fraction was desalted and concentrated using an Amicon membrane with a molecular weight of 1000, and then equilibrated with 0.03M Na2C03-NaHC03 buffer. Bilirupine oxidase NS charged onto a 100 column and eluted
-1 active fractions were collected and freeze-dried to obtain purified bilirubin oxidase NS-1. This purified product was uniform in polyacrylamide gel disk electrophoresis. Next, the measurement of bilirubin oxidase activity in the present invention will be described.

EDTA1mMを含む0.2Mトリスー塩酸緩衝液(p
H8.4)250叫にビリルビン5双9を溶解した液2
.0の上と酵素標品0.2地をセルに供し、370で反
応させた後、初速度を測定する。
0.2M Tris-HCl buffer (p
H8.4) Solution 2 of bilirubin 5 and 9 dissolved in 250 mg
.. 0 and the enzyme preparation 0.2 are placed in a cell, and after reacting at 370, the initial velocity is measured.

即ち44瓜mでの吸光度を光度計で経時的に追っていき
、1分間当り1マイクロモルのビリルビンを酸化する酵
素量を1単位とする。本発明の酵素がオキシダーゼであ
る事の証明について以下述べる。本発明の酵素は無酸素
状態では反応は進行しない。
That is, the absorbance at 44 m is followed over time using a photometer, and the amount of enzyme that oxidizes 1 micromole of bilirubin per minute is defined as 1 unit. The proof that the enzyme of the present invention is an oxidase will be described below. The reaction of the enzyme of the present invention does not proceed under anoxic conditions.

又、ワールブルグ(Warburg)検圧計では酸素を
吸収する挙動をとる。したがってオキシダーゼ(0幻d
ase)又はオキシゲナーゼ(0広ygeMse)と予
測される。
Furthermore, the Warburg manometer has a behavior of absorbing oxygen. Therefore, oxidase (0 phantom d
Ase) or oxygenase (0 ygeMse).

そこでビリルビン、ピロガロール(Pyrogallo
l)を基質とし、本発明の酵素を作用させた場合の反応
生成物の確認をした。‘1} ピリルビンに対する作用 ビリルビン(Sigma社製、結晶品)6の9を0.2
Mトリスー塩酸緩衝液(pH8.2)5の‘に溶解した
溶液3.0の‘と酵素溶液(12.血/叫)0.1泌を
370、10分間反応させた後、未反応のピリルビンを
除くためクロロホルムに抽出し、水層をセフアデックス
G−15(SephadexG−15)カラムにかけた
Therefore, bilirubin, pyrogallol (Pyrogallo)
The reaction product was confirmed when the enzyme of the present invention was applied to 1) as a substrate. '1} Effect on pirirubin Bilirubin (manufactured by Sigma, crystalline product) 6-9 is 0.2
After reacting a solution of 3.0% dissolved in 5% M Tris-HCl buffer (pH 8.2) and 0.1% enzyme solution (12% blood/scream) for 10 minutes, unreacted pirirubin was removed. The aqueous layer was applied to a Sephadex G-15 column.

階紫色の画分はカラムを素通りしたが、青線色の物質は
セフアデツクスに吸着したままであった。そこでカラム
からセフアデックスを取り出しメタノール中浸潰し、光
を当てずに、5℃約5時間吸着物の溶出を行った。その
後、櫨過してセフアデックスを除き、櫨液について可視
スペクトルと薄層クロマトグラフィーにかけた。
The purple fraction passed through the column, but the blue substance remained adsorbed on the Cephadex. Therefore, the Sephadex was taken out from the column and immersed in methanol, and the adsorbed material was eluted at 5° C. for about 5 hours without exposing it to light. Thereafter, the Cephadex was removed by sieving, and the cephadex was subjected to visible spectrum and thin layer chromatography.

その結果66仇mと37則m付近に吸収極大を持つこと
および、薄層クロマトグラフィーのスポットが単一であ
り、しかも対照として入れた標準ビリベルジン(Sig
ma社製、純度約80%)のRf値と同じであることよ
り反応液中にはピリルビン(分子式C33&6N406
)の酸化物であるピリベルジン(分子式C33比4N4
06)が存在していることがわかった。‘21 ピロガ
ロールに対する作用 本発明の酵素はビリルビンに比べ1/1の 塁度ではあ
るが、ピロガロールにも反応する。
The results showed that there was an absorption maximum near 66m and 37m, and that the thin layer chromatography spot was single, and that the standard biliverdin (Sig) used as a control
Since the Rf value is the same as that of Pyrrubin (Molecular formula: C33 & 6N406, manufactured by MA), the reaction solution contains
) is an oxide of pyliverdine (molecular formula C33 ratio 4N4
06) was found to exist. '21 Action on pyrogallol The enzyme of the present invention also reacts with pyrogallol, although the degree of reaction is 1/1 that of bilirubin.

ピロガロール水溶液(5の9/の【)5.0叫と酵素溶
液(26.6ム/の‘)0.3泌を前記{1}と同様に
反応させ、反応溶液中に析出した燈色の結晶を櫨遇し乾
燥後、IR、NMRスペクトルをとった。その結果をジ
・アルドリツチ・ライブラリー・オブ・インフラアレツ
ド・スベクトラ(TheNdrjch Library
oflnfraredSpectra)およびジ・アル
ドリツチ・ライブラリー・オブ・NMRスベクトラ(T
heNdrichLibraびofNM股Spectr
a)と参照比較したところブルブロガリン(Purpu
rogallin)が生成されていることがわかった。
プルブロガリン(分子式C6は03)はピロガロール(
分子式C,.日8Q)をパーオキシダーゼ(Perox
iぬse)・比02と反応させた場合の産物でもある。
以上の結果より本発明の酵素は分子状の酸素を電子受容
体として酸化反応を触媒するオキシダーゼであり、更に
詳しくはビリルビンをビリベルジンに酸化するビリルビ
ンオキシダーゼである。
Pyrogallol aqueous solution (5 of 9/') 5.0 ml and enzyme solution (26.6 ml/') of 0.3 ml were reacted in the same manner as in {1} above, and the light-colored color precipitated in the reaction solution. After drying the crystals, IR and NMR spectra were taken. The results were published in The Ndrjch Library of Infrared Svektra.
oflnfraredSpectra) and The Aldrich Library of NMR Spectra (T
heNdrichLibra and ofNM crotch Spectr
When compared with reference a), bulbrogarin (Purpu
It was found that rogallin) was produced.
Purbrogalin (molecular formula C6 is 03) is pyrogallol (
Molecular formula C,. day 8Q) peroxidase (Perox
It is also a product when reacted with inuse)・ratio02.
From the above results, the enzyme of the present invention is an oxidase that catalyzes an oxidation reaction using molecular oxygen as an electron acceptor, and more specifically, it is a bilirubin oxidase that oxidizes bilirubin to biliverdin.

本ビリルビンオキシダーゼNS−1は下記の性質を持つ
。‘1} 作用:ビリルビンを分子状酸素の存在下に酸
化し、緑色物質、淡緑色物質を経て淡紫色物質を生成す
るも過酸化水素を生成しない。
The present bilirubin oxidase NS-1 has the following properties. '1} Action: Oxidizes bilirubin in the presence of molecular oxygen, producing a green substance, a pale green substance, and then a pale purple substance, but does not produce hydrogen peroxide.

生成物中にはビリベルジンが含まれる。‘2) 基質特
異性:6.84mMの各種基質(0.2けりン酸緩衝液
、pH8.0に溶解)10の‘と本ビリルビンオキシダ
ーゼNS−1酵素溶液(2.血/泌)1.0肌を370
で反応させた。
Biliverdin is included in the product. 2) Substrate specificity: 6.84mM of various substrates (dissolved in 0.2 phosphate buffer, pH 8.0) 10' and the present bilirubin oxidase NS-1 enzyme solution (2. blood/secretion)1. 0 skin 370
I reacted with

ピリルピンを100としたときの相対活性を第1表に示
した。第1表 基質特異性 (夫) わずかに反応、 {3} 温度安定性:本酵素を0.1Mリン酸緩衝液(
pH8.0)中で15分間、各温度で処理した後、残存
活性を測定した。
Table 1 shows the relative activity when pirirupine is set as 100. Table 1 Substrate specificity (husband) Slight reaction, {3} Temperature stability: This enzyme was dissolved in 0.1M phosphate buffer (
After treatment at each temperature for 15 minutes in pH 8.0), residual activity was measured.

第1図に示すように、5000では90%以上の残存を
示したが、7000では失活する(第1図)。■ 至適
温度:pH8において、各温度における活性を測定した
As shown in FIG. 1, at 5000, more than 90% remained, but at 7000, the activity was lost (FIG. 1). ■ Optimum temperature: At pH 8, activity was measured at each temperature.

その結果4000における活性が最高であった(第2図
)。‘5’pH安定性:本酵素液を各pHで370、6
06間放置した後、pHを8に戻し残存活性を測定した
As a result, the activity at 4000 was the highest (Fig. 2). '5' pH stability: This enzyme solution was 370, 6 at each pH.
After standing for 0.6 hours, the pH was returned to 8 and the residual activity was measured.

その結果斑6から餌10までの間で安定であった(第3
図)。t61 至薄歌:結晶ビリルビンは酸性、中性域
では不落性であるため、アルブミン結合型ビリルビン(
デイド社製、商品名ビリルビンコントロール)を基質と
して、母6〜10の範囲において37℃で反応を行った
As a result, it was stable from spot 6 to bait 10 (3rd
figure). t61 Shihaku: Since crystalline bilirubin does not fall in the acidic or neutral range, albumin-bound bilirubin (
The reaction was carried out at 37°C in the range of 6 to 10 using Bilirubin Control (trade name, manufactured by Dade Corporation) as a substrate.

その結果柵6〜7が反応の至適であった(第4図)。‘
71 分子量:セフアデツクスG−100(ファルマシ
ア製)カラム(径2.5肌×長さ92肌)を3MMNを
CQ・NaHC03緩衝液(pH9.3)で平衡化して
分子量の測定を行った。
As a result, fences 6 and 7 were found to be optimal for reaction (Fig. 4). '
71 Molecular weight: The molecular weight was measured using a Cephadex G-100 (manufactured by Pharmacia) column (2.5 skins in diameter x 92 skins in length) with 3 MMN equilibrated with CQ/NaHC03 buffer (pH 9.3).

その結果本酵素の分子量は約52000であった。なお
、標準蛋白としてはチトクロームC(分子量12400
)、卵白アルプミン(分子量43000)、牛血清アル
ブミン(分子量66000)、yーグロブリン(分子量
160000)を使用した。
As a result, the molecular weight of this enzyme was approximately 52,000. The standard protein used is cytochrome C (molecular weight 12,400
), oval albumin (molecular weight 43,000), bovine serum albumin (molecular weight 66,000), and y-globulin (molecular weight 160,000) were used.

【8ー 等電点:LKB社製焦点電気泳動装置(容量1
10の【)、アンフオラィン(LKB社製、pH3.5
〜5.0)を使用して冷却下(0℃)で600V、48
時間泳動後2.5必ずつ分画して等重点を求めた。
[8- Isoelectric point: LKB focusing electrophoresis device (capacity 1
10 [), Ampholine (manufactured by LKB, pH 3.5
~5.0) under cooling (0°C) at 600V, 48
After time phoresis, the fraction was fractionated into 2.5 fractions and the isocenters were determined.

本酵素の等露点‘まPI=4.1であった。【9} デ
ィスク電気泳動:7%ポリアクリルアミドゲル(pH9
.5)を使用しディビスの方法(B.J.Davis,
Ann.N.Y.Acad.Sci.121 404(
1964))に従って行った。2本泳動し、一方は染色
、もう一方は2柳単位で切って活性測定をして泳敷位置
を決めた。
The isodew point of this enzyme was PI=4.1. [9} Disk electrophoresis: 7% polyacrylamide gel (pH 9
.. 5) using Davis' method (B.J. Davis,
Ann. N. Y. Acad. Sci. 121 404 (
1964)). Two tubes were run, one was stained, the other was cut into 2 willow units, activity was measured, and the position of the electrophoresis layer was determined.

その結果、酵素蛋白は単一バンドとなり、活性の位置と
一致した。‘IQ アミノ酸分析:本酵素を鮒定沸点塩
酸にて減圧下110qoで24,48,72時間加水分
解し、ついで、加水分解物を減圧乾固して十分塩酸を除
いたのち、0.0則けクエン酸緩衝液(pH2.2)に
溶解した。
As a result, the enzyme protein formed a single band, which coincided with the active position. 'IQ Amino acid analysis: This enzyme was hydrolyzed with carp constant boiling point hydrochloric acid at 110 qo under reduced pressure for 24, 48, and 72 hours, and then the hydrolyzate was dried under reduced pressure to sufficiently remove the hydrochloric acid. and dissolved in citrate buffer (pH 2.2).

この溶液を日立KLA−5型自動アミノ酸分析機にて分
析した。トリプトフアン、チロシンの含量はC℃odM
n−Monon法に従って行った。(T.W.G℃od
wjnand R.A.Morbn,Biochem.
J.40、628(1964))。シスチンの定量は本
酵素を過ギ酸酸化後、過ギ酸を臭化水素で除き(S.M
oore,J.Biol.Chem.238、235(
1963))、州定沸点塩酸にて110qoで1糊時間
分解し、ついで、加水分解物を減圧乾燥して十分塩酸を
除いたのち、0.09Mクエン酸緩衝液(pH2.2)
に溶解した。この溶液を日立KLA−5型自動アミノ酸
分析機にて分析した。結果を第2表に示す。
This solution was analyzed using a Hitachi KLA-5 automatic amino acid analyzer. The content of tryptophan and tyrosine is C℃odM
It was performed according to the n-Monon method. (T.W.G℃od
wjnand R. A. Morbn, Biochem.
J. 40, 628 (1964)). Cystine was quantified by oxidizing the enzyme with performic acid, and then removing the performic acid with hydrogen bromide (S.M.
oore, J. Biol. Chem. 238, 235 (
1963)), the glue was decomposed in constant boiling point hydrochloric acid at 110 qo for 1 hour, and then the hydrolyzate was dried under reduced pressure to sufficiently remove the hydrochloric acid, and then added to 0.09M citric acid buffer (pH 2.2).
dissolved in This solution was analyzed using a Hitachi KLA-5 automatic amino acid analyzer. The results are shown in Table 2.

第2表 アミノ酸組成 (11)金属ィオンの影響:本酵素を5皿Mトリスー塩
酸緩衝液(pH8.3)に溶解し、これに各金属イオン
が10‐2Mになるように添加したのち、2500、5
分間処理した。
Table 2 Amino acid composition (11) Effect of metal ions: This enzyme was dissolved in 5 plates of M Tris-HCl buffer (pH 8.3), and each metal ion was added to this at a concentration of 10-2M. , 5
Processed for minutes.

その後活性測定を行った。なおCが十については10−
3Mで処理した。結果は第3表に示すごとくFe2十に
より著しく阻害される。3− 金属ィオンの影響 (12)阻害剤等の影響:本酵素溶液を各種阻害剤とp
H8、室温、1の片間処理したのち1M餅こ希釈して活
性を測定した。
Thereafter, activity measurements were performed. In addition, for C is 10, it is 10-
Treated with 3M. As shown in Table 3, the results are significantly inhibited by Fe20. 3- Effect of metal ions (12) Effect of inhibitors, etc.: This enzyme solution was mixed with various inhibitors.
After treatment with H8 at room temperature for 1 hour, the mixture was diluted with 1M Mochiko and the activity was measured.

重金属と錆体をつくるシアン化カリウム、アジ化ナトリ
ウム、チオ尿素によって阻害される。(第4表)。第4
表 阻害剤等の影響 (13)可視部吸収:本酵素溶液(1%)の可視部にお
ける吸収を測定した。
It is inhibited by heavy metals and potassium cyanide, sodium azide, and thiourea, which form rust bodies. (Table 4). Fourth
Table: Effects of inhibitors, etc. (13) Absorption in the visible region: Absorption in the visible region of this enzyme solution (1%) was measured.

その結果375nmおよび46皿m付近に吸収極大をも
たない。すなわち、本酵素はFAD(F1avine
adeninedinucleotide )、
FMN ( F1avjnemononuc1eo
tide)にある特異吸収をもたない。(14)糖含量
:7%ポリアクリルアミドゲル(PH8.0)を使用し
、ディスク電気泳動を行い糖の染色をした(PAS染色
:R.M.ねcharius,T.E.all,T.日
.Monison,J.J.Woodlock,Ana
l.Biochem.30148(1969))。
As a result, there is no absorption maximum near 375 nm and 46 m. That is, this enzyme is FAD (F1avine
adenine nucleotide),
FMN (F1avjnemononuc1eo
It does not have the specific absorption that exists in tides. (14) Sugar content: Using 7% polyacrylamide gel (PH8.0), disk electrophoresis was performed and sugar staining (PAS staining: R.M. Necharius, T.E. all, T. . Monison, J. J. Woodlock, Ana
l. Biochem. 30148 (1969)).

その結果蛋白染色部と同一の部分が染色されたことによ
り、酵素中に糖が含まれることがわかった。フェノール
硫酸法により糠含量を定量したところグルコースとして
約7.8%であった。(15)銅舎量:本酵素を硝酸で
加熱分解後、放冷し過塩素酸を加え静かに加熱沸騰させ
る。
As a result, the same area as the protein staining area was stained, indicating that sugar was contained in the enzyme. The bran content was determined by the phenol-sulfuric acid method and was approximately 7.8% as glucose. (15) Amount of copper: After heating and decomposing this enzyme with nitric acid, allow it to cool, add perchloric acid, and gently heat to boil.

冷却後PerkinElmer402型原子吸光分析機
で銅の定量を行った。その結果酵素1モル中に銅1モル
が含まれていることがわかった。(16)塩化ナトリウ
ムの影響:各濃度の塩化ナトリウムを含有する本酵素溶
液の活性を測定した結果、高濃度になるほど活性が阻害
されることがわかった。
After cooling, copper was quantified using a PerkinElmer 402 atomic absorption spectrometer. As a result, it was found that 1 mol of copper contained 1 mol of enzyme. (16) Effect of sodium chloride: As a result of measuring the activity of this enzyme solution containing various concentrations of sodium chloride, it was found that the higher the concentration, the more the activity was inhibited.

(第5表)。ただし透析により塩化ナトリウムを除け‘
ざ活性は回復する。
(Table 5). However, sodium chloride is removed by dialysis.
The activity recovers.

第5表 塩化ナトリゥムの影響 次に本発明の試験例および実施例を示す。Table 5 Effects of sodium chloride Next, test examples and examples of the present invention will be shown.

試験例 1 ミロセシウム・ベルカリアMT−1、FERM−P恥.
5918及びミロセシウム属に属する保存菌株を用いて
ビリルビンオキシダーゼNS−1生産能を調べた。
Test Example 1 Myrocesium Berkaria MT-1, FERM-P Shame.
The ability to produce bilirubin oxidase NS-1 was investigated using B. 5918 and preserved strains belonging to the genus Myrocesium.

培地としてグルコース・ジャガイモ塔地(ジャガイモ4
00夕に水1そを加え煮沸し、冷却後、ガーゼで櫨過し
、櫨液を1のこメスアップしたものにグリコース1%を
加え斑を5.8に調整して作製)を各100のこを用い
500の‘の坂口フラスに入れ、各保存菌株を接種し、
2500にて各時間培養し、培養液中のビリルビンオキ
シターゼ活性を調べた。その結果を第6表に示す。
Glucose-potato soil (potato 4) was used as a medium.
Add 1 tsp of water at night, boil, cool, pass through gauze, add 1% glycose to 1 tsp of lint liquid, adjust the mottling to 5.8) and make 100 each. Using a saw, put it into a 500' Sakaguchi flask and inoculate each stock strain,
The cells were cultured at 2500 °C for various hours, and the bilirubin oxidase activity in the culture solution was examined. The results are shown in Table 6.

第 6 表 第6表の結果より明らかの如く、Myrothecim
mverrucaria MT−1 FERM− P
No.5918(FERM−BP653に変更)以
外にもMymtheci山mverrucaria I
F0 6113、MMothecium verruc
arlaIF0 6133 、 Myrotheciu
m verrucaria IF06351、Myro
thecium verrucaria IFO 90
56、Myr。
Table 6 As is clear from the results in Table 6, Myrothecim
mverrucaria MT-1 FERM-P
No. In addition to 5918 (changed to FERM-BP653), Mymtheci mverrucaria I
F0 6113, MMothecium verruc
arlaIF0 6133, Myrotheciu
m verrucaria IF06351, Myro
thecium verrucaria IFO 90
56, Myr.

theC肌m r。ridumIF。9531・Myr
theC skin m r. ridumIF. 9531・Myr
.

theCMmci肌tum IFO9950にビリルビ
ンオキシダーゼNS−1生産能があることが判る。実施
例 1 Myrothecimm vermcariaMT−1
,FERM−PNo.5918を試験例1の記載のグル
コース・ジャガイモ培地100の【を500M坂口フラ
スコに入れたものに接種し、25℃で72時間振濠培養
(15仇pm)し、得られた種培養物を、あらかじめ1
0そ容量のジャーフアメンターに殺菌した7そのグルコ
ース・ジャガイモ培地及び消泡剤アデカノールLG12
6を0.07%添加したものの中に接種する(接種量は
2%)。
It is found that theCMmci skin tum IFO9950 has the ability to produce bilirubin oxidase NS-1. Example 1 Myrothecimm vermcaria MT-1
, FERM-PNo. 5918 was inoculated into a 500M Sakaguchi flask containing 100% of the glucose potato medium described in Test Example 1, cultured in a shaking moat (15 pm) at 25°C for 72 hours, and the resulting seed culture was 1 in advance
7. Glucose potato medium sterilized in a jar of 0.0 volume and antifoam agent Adekanol LG12
6 was added at 0.07% (the amount of inoculation was 2%).

培養温度2500、澄梓25仇pm、通気量6そ/mi
nの条件で6網時間培養し、培養終了後、除菌し、培養
櫨液3000の上を得る。
Culture temperature 2500, clear water 25 pm, ventilation rate 6 so/mi
The cells were cultured for 6 hours under the conditions of n, and after the completion of the culture, bacteria were removed to obtain a culture solution 3000.

このもののビリルビンオキシダーゼ活性は19.血/泌
であった。実施例 2 Myrothec肌m verrucaria IF0
6133を用いて実施例1と全く同様に処理し、7そ
の培地よりビリルビンオキシダーゼ活性14.0u/の
‘を含む培養液3500私を得た。
The bilirubin oxidase activity of this product is 19. It was blood/secretion. Example 2 Myrothec skin m verrucaria IF0
6133 was treated in exactly the same manner as in Example 1, and 3,500 microliters of culture solution containing bilirubin oxidase activity of 14.0 u/' was obtained from the medium.

実施例 3 MyrothecimmroridumIFO9531
を用いて、実施例1と全く同機に処理し、7夕の培地よ
りビリルビンオキシダーゼ活性7.5uノ地上を含む培
養液3300の‘を得た。
Example 3 Myrothecimmroridum IFO9531
The cells were treated in exactly the same manner as in Example 1, and 3300' of culture solution containing 7.5 u of bilirubin oxidase activity was obtained from the 7 days old culture medium.

実施例 4 実施例1で得られた培養櫨液3000の‘に0.8飽和
まで硫安を加え、一晩5℃に放置後、沈澱部分を溶解し
、イオン交換水を用い、5℃で十分透析する。
Example 4 Ammonium sulfate was added to 3,000 ml of the cultured oak solution obtained in Example 1 to a saturation level of 0.8, and after standing at 5°C overnight, the precipitated portion was dissolved. Dialyze.

透折終了後、透折内液に活性炭を0.7%量添加し、櫨
過する。譲渡液のpHを7.4に調整し、さらに活性炭
を0.2%量を添加し、櫨過する。この櫨液を0.鮒ア
ンモニア水で解9.3に調整後、あらかじめ0.018
MNa2CQ−NaHC03緩衝液(pH9.3)で平
衡化した○〜AE−Sephadex A−50の力ラ
ムクロマトグラフイ一にかけ、ビリルピンオキシダーゼ
を吸着せしめ、洗浄後、同緩衝液(0.015〜0.8
ゆ でグラジェントにて溶出し、活性画分を分子量10
00のアミコン膜で脱塩濃縮し、さらに0.03MNa
2C03一NaHC03緩衝液で平衡化したセフアデツ
クスG−100のカラムクロマトグラフイーにチャージ
し、溶出してくるビリルビンオキシダーゼ活性画分を集
め凍結乾燥を行うことにより精製ビリルビンオキシダー
ゼNS−1を得た。
After the diafiltration is completed, activated carbon is added in an amount of 0.7% to the diafiltration solution, and the mixture is filtered through a filter. The pH of the transfer liquid was adjusted to 7.4, and 0.2% of activated carbon was added and filtered. Add this citrus liquid to 0. After adjusting the solution to 9.3 with carp ammonia water, the solution was 0.018 in advance.
Bilirupine oxidase was adsorbed by column chromatography on ○~AE-Sephadex A-50 equilibrated with MNa2CQ-NaHC03 buffer (pH 9.3), and after washing, the same buffer (0.015~0 .8
Elute with a boiled gradient, and collect the active fraction with a molecular weight of 10.
Desalt and concentrate with 0.00 Amicon membrane and further add 0.03 MNa.
Purified bilirubin oxidase NS-1 was obtained by charging the column chromatography column of Sephadex G-100 equilibrated with 2C03-NaHC03 buffer, collecting the eluted bilirubin oxidase active fraction, and freeze-drying it.

この精製品はポリアクリルアミドゲルデイスク電気泳動
的に単一であった。精製過程の収率などを第7表に示す
。第7表 ビリルピンオキシダーゼNS−1の精製
This purified product was uniform in polyacrylamide gel disk electrophoresis. Table 7 shows the yield of the purification process. Table 7 Purification of bilirupine oxidase NS-1

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明のピリルビンオキシダーゼの温度安定性
を示す図であり、第2図は同じく至適温度を、第3図は
pH安定性を、第4図は至通pHをそれぞれ示す図であ
る。 第1図 第2図 第3図 第4図
Figure 1 is a diagram showing the temperature stability of the pirirubin oxidase of the present invention, Figure 2 is a diagram showing the optimum temperature, Figure 3 is a diagram showing pH stability, and Figure 4 is a diagram showing the optimum pH. be. Figure 1 Figure 2 Figure 3 Figure 4

Claims (1)

【特許請求の範囲】 1 次の理化学的性質を有するビリルビンオキシダーゼ
NS−1。 (1) 作用:ビリルビンを分子状酵素の存在下に酸化
し、緑色物質、淡緑色物質を経て淡紫色物質を生成する
も過酸化水素を生成しない。 (2) 基質特異性:ビリルビンに反応する。 ビリベルジン、ヘミン、ヘマトポリフイリン、クロロフ
イリンには若干反応する。ヘモグロビン、クロロフイル
、ビタミンB_1_2には反応しない。(3) 温度お
よびpH安定性:pH8.0(0.1Mリン酸緩衝液)
、50℃、15分処理で90%以上残存し、70℃、1
5分では失活する。37℃,60分処理においてpH5
〜pH10.5の間で95%以上残存する。 (4) 至適温度:40℃付近。(5) 至適pH:p
H6〜7。 (6) 分子量:約52000(ゲル濾過法)(7)
等電点:PI=4.1(8) 金属イオンの影響:F^
2^+_eにより著しく阻害される。 (9) 阻害剤等の影響:シアン化カリウム、アジ化ナ
トリウム、チオ尿素によって阻害される。 (10) 可視部吸収:375nmおよび46nm付近
に吸収極大がない。(11) 糖を約7.8%含む。 (12) 1モル中に銅1モルを含む。 2 ビリルビンオキシダーゼNS−1生産菌がミロセシ
ウム属に属する菌である特許請求の範囲第1項記載のビ
リルビンオキシダーゼNS−1。
[Claims] Bilirubin oxidase NS-1 having the following physical and chemical properties. (1) Action: Oxidizes bilirubin in the presence of molecular enzymes, producing a green substance, a pale green substance, and then a pale purple substance, but does not produce hydrogen peroxide. (2) Substrate specificity: Reacts with bilirubin. It reacts slightly with biliverdin, hemin, hematoporphyllin, and chlorophyllin. It does not react with hemoglobin, chlorophyll, or vitamin B_1_2. (3) Temperature and pH stability: pH 8.0 (0.1M phosphate buffer)
, more than 90% remained after treatment at 50℃ for 15 minutes, and at 70℃, 1
It becomes inactive in 5 minutes. pH 5 after treatment at 37℃ for 60 minutes
-95% or more remains between pH 10.5. (4) Optimum temperature: around 40℃. (5) Optimal pH: p
H6-7. (6) Molecular weight: Approximately 52,000 (gel filtration method) (7)
Isoelectric point: PI = 4.1 (8) Effect of metal ions: F^
It is significantly inhibited by 2^+_e. (9) Effects of inhibitors, etc.: Inhibited by potassium cyanide, sodium azide, and thiourea. (10) Visible absorption: There is no absorption maximum near 375 nm and 46 nm. (11) Contains about 7.8% sugar. (12) Contains 1 mol of copper in 1 mol. 2. Bilirubin oxidase NS-1 according to claim 1, wherein the bilirubin oxidase NS-1 producing bacterium is a bacterium belonging to the genus Myrocesium.
JP57025613A 1982-02-18 1982-02-18 bilirubin oxidase NS-1 Expired JPS6012032B2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP57025613A JPS6012032B2 (en) 1982-02-18 1982-02-18 bilirubin oxidase NS-1
DE3249743A DE3249743C2 (en) 1982-02-18 1982-10-20
DE19823239236 DE3239236A1 (en) 1982-02-18 1982-10-20 Total or conjugated bilirubin determn. - using bilirubin oxidase or laccase, opt. in presence of surfactant, aromatic-carboxylic acid, sulpha drug or protease
FR8217632A FR2521589B1 (en) 1982-02-18 1982-10-21 METHOD FOR THE QUANTITATIVE DETERMINATION OF PHYSIOLOGICAL COMPONENTS IN BIOLOGICAL FLUIDS
US06/436,385 US4554249A (en) 1982-02-18 1982-10-25 Method for the quantitative determination of physiological components in biological fluids
GB08230397A GB2115926B (en) 1982-02-18 1982-10-25 Method for the quantitative determination of physiological components in biological fluids
CA000414104A CA1185883A (en) 1982-02-18 1982-10-25 Method for the quantitative determination of bilirubin in biological fluids
CA000464110A CA1218586A (en) 1982-02-18 1984-09-26 Method for the quantitative determination of physiological components in biological fluids
FR8419005A FR2556010B1 (en) 1982-02-18 1984-12-12 METHOD FOR THE QUANTITATIVE DETERMINATION OF PHYSIOLOGICAL COMPONENTS IN BIOLOGICAL FLUIDS
GB08431875A GB2152215B (en) 1982-02-18 1984-12-18 Method for the quantitative determination of physiological components in biological fluids
US06/749,425 US4839279A (en) 1982-02-18 1985-06-27 Method for the quantitative determination of physiological components in biological fluids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57025613A JPS6012032B2 (en) 1982-02-18 1982-02-18 bilirubin oxidase NS-1

Publications (2)

Publication Number Publication Date
JPS58141783A JPS58141783A (en) 1983-08-23
JPS6012032B2 true JPS6012032B2 (en) 1985-03-29

Family

ID=12170731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57025613A Expired JPS6012032B2 (en) 1982-02-18 1982-02-18 bilirubin oxidase NS-1

Country Status (1)

Country Link
JP (1) JPS6012032B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701411A (en) * 1983-09-01 1987-10-20 Eastman Kodak Company Bilirubin-specific enzyme preparation, assay compositions, analytical elements and methods using same

Also Published As

Publication number Publication date
JPS58141783A (en) 1983-08-23

Similar Documents

Publication Publication Date Title
Taniguchi et al. The oxidase system of heterotrophically-grown Rhodospirillum rubrum
JP3157622B2 (en) Fructosylamine deglycase, method for producing the same, and method for quantifying amadori compound using the enzyme
FR2555196A1 (en) NOVEL BILIRUBINE OXIDASE, PROCESS FOR PRODUCING THE SAME, REACTIVE COMPOSITION CONTAINING THE SAME AND USE THEREOF FOR ASSAYING BILIRUBIN
FR2576909A1 (en) THERMOSTABLE BILIRUBIN OXIDASE AND PROCESS FOR OBTAINING SAME
EP0248400A2 (en) Enzyme and process for its preparation
JPH0440987B2 (en)
JPS6012031B2 (en) Method for producing bilirubin oxidase
CA1207261A (en) Production of bilirubin oxidase
JPS6012032B2 (en) bilirubin oxidase NS-1
DE3931399A1 (en) N-ACETYLHEXOSAMINE-DEHYDROGENASE, PROCESS FOR THE PRODUCTION THEREOF, METHOD FOR THE QUANTITATIVE ANALYSIS OF N-ACETYLGLUCOSAMINE OR N-ACETYLGALACTOSAMINE USING THE SAME, AND KIT FOR QUANTITATIVE ANALYSIS
JPH07246092A (en) Catalase and method for producing the same
US4394450A (en) Method for purification of uricase
DE2906737C2 (en) L-lysine α-oxidase, method for obtaining it and its use
JPS6143987A (en) Peroxidase and its preparation
JPS5934882A (en) Biosensor
JPS58165789A (en) Preparation of alpha-glycerophosphate oxidase
JPS6098982A (en) Preparation of enzyme for measuring polyamine
JPS60244286A (en) Preparation of oxalic acid oxidase
JPS61285989A (en) Phenol oxidase and production thereof
JPS6031473B2 (en) Method for producing polyamine oxidases using microorganisms
JPS6013666B2 (en) Microbial polyamine oxidase PC-3 and its production method
JPS58146297A (en) Determination method of polyamine
JPS61128891A (en) Production of formic acid
JPS6023835B2 (en) L-α-glycerophosphate oxidase
JPS5995886A (en) L-tryptophan aminopeptidase and its preparation